Product Information
KEPPRA 100 MG/ML ORAL SOLN is a brand product labeled by UCB, Inc., priced at $1.9186 per ML under NDC 50474000148. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 15, 2003. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the levetiracetam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/mL
Manufacturer
UCB, Inc.NDC
50474000148
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
New Drug (NDA)
FDA Application
NDA021505FDA Approved
7/15/2003
TE Code
AA
On Market Since
10/20/2003
Pharmacological Classes
Price Statistics
The NADAC for KEPPRA 100 MG/ML ORAL SOLN has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9186 per ML |
|---|---|
| All-time high | $1.9234 (May 13, 2026) |
| All-time low | $1.0657 (Dec 18, 2013) |
| 52-week high | $1.9234 |
| 52-week low | $1.8746 |
| Median price | $1.4967 |
| Average price | $1.5422 |
| Largest weekly change | +9.9% (Jan 8, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KEPPRA 100 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for KEPPRA 100 MG/ML ORAL SOLN, manufactured by UCB, Inc., is $1.9186 per ML (NDC 50474000148), effective Aug 19, 2026.
How has the price of KEPPRA 100 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for KEPPRA 100 MG/ML ORAL SOLN has risen 78.3%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KEPPRA 100 MG/ML ORAL SOLN?
Since Nov 28, 2013, the NADAC for KEPPRA 100 MG/ML ORAL SOLN has ranged from a low of $1.0657 (Dec 18, 2013) to a high of $1.9234 (May 13, 2026), with a median of $1.4967 per ML.
Are there cheaper alternatives to KEPPRA 100 MG/ML ORAL SOLN?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 100 MG/ML SOLN, is $0.0301 per ML — about 98% below KEPPRA 100 MG/ML ORAL SOLN.
Who manufactures KEPPRA 100 MG/ML ORAL SOLN?
KEPPRA 100 MG/ML ORAL SOLN (NDC 50474000148) is labeled by UCB, Inc., and CMS classifies it as a brand product.